Related references
Note: Only part of the references are listed.Counselling framework for moderate-penetrance cancer-susceptibility mutations
Nadine Tung et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Inherited Mutations in Women With Ovarian Carcinoma
Barbara M. Norquist et al.
JAMA ONCOLOGY (2016)
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline BRCA-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
Geoffrey Kim et al.
CLINICAL CANCER RESEARCH (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Bella Kaufman et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT) A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology
Donavan T. Cheng et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2015)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer
Susan J. Ramus et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Hypersensitivities for Acetaldehyde and Other Agents among Cancer Cells Null for Clinically Relevant Fanconi Anemia Genes
Soma Ghosh et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Comprehensive Sequencing of PALB2 in Patients With Breast Cancer Suggests PALB2 Mutations Explain a Subset of Hereditary Breast Cancer
Priscilla H. Fernandes et al.
CANCER (2014)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Breast-Cancer Risk in Families with Mutations in PALB2
A. C. Antoniou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Breast cancer-associated missense mutants of the PALB2 WD40 domain, which directly binds RAD51C, RAD51 and BRCA2, disrupt DNA repair
J-Y Park et al.
ONCOGENE (2014)
The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1- and BRCA2-Negative Hereditary Breast Cancer
Marketa Janatova et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Ana Blanco et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Rare occurrence of PALB2 mutations in ovarian cancer patients from the Volga-Ural region
D. Prokofyeva et al.
CLINICAL GENETICS (2012)
ChAM, a novel motif that mediates PALB2 intrinsic chromatin binding and facilitates DNA repair
Jean-Yves Bleuyard et al.
EMBO REPORTS (2012)
Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States
Yuan Chun Ding et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer
Paolo Peterlongo et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
Silvia Casadei et al.
CANCER RESEARCH (2011)
PALB2 mutations in familial breast and pancreatic cancer
Erin W. Hofstatter et al.
FAMILIAL CANCER (2011)
Germline Mutations in the PALB2 Gene Are Population Specific and Occur with Low Frequencies in Familial Breast Cancer
Heide Hellebrand et al.
HUMAN MUTATION (2011)
A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
Agnieszka Dansonka-Mieszkowska et al.
BMC MEDICAL GENETICS (2010)
Screening for genomic rearrangements in BRCA1 and BRCA2 genes in Czech high-risk breast/ovarian cancer patients: high proportion of population specific alterations in BRCA1 gene
Ivana Ticha et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
PALB2 mutations in European familial pancreatic cancer families
E. P. Slater et al.
CLINICAL GENETICS (2010)
Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval
Peter C. Fong et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
Andrew Tutt et al.
LANCET (2010)
Genome destabilization by homologous recombination in the germ line
Mariko Sasaki et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination
Remi Buisson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
A mobile threat to genome stability: The impact of non-LTR retrotransposons upon the human genome
Miriam K. Konkel et al.
SEMINARS IN CANCER BIOLOGY (2010)
A PALB2 mutation associated with high risk of breast cancer
Melissa C. Southey et al.
BREAST CANCER RESEARCH (2010)
PALB2 Links BRCA1 and BRCA2 in the DNA-Damage Response
Feng Zhang et al.
CURRENT BIOLOGY (2009)
Structural basis for recruitment of BRCA2 by PALB2
Antony W. Oliver et al.
EMBO REPORTS (2009)
Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer
Marc D. Tischkowitz et al.
GASTROENTEROLOGY (2009)
PALB2 Regulates Recombinational Repair through Chromatin Association and Oligomerization
Shirley M. -H. Sy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Shirley M. H. Sy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
Sian Jones et al.
SCIENCE (2009)
Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer
Anna Potapova et al.
CANCER RESEARCH (2008)
A synthetic lethal therapeutic approach: Poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair
Alan Ashworth
JOURNAL OF CLINICAL ONCOLOGY (2008)
Analysis of PALB2/FANCN-associated breast cancer families
Marc Tischkowitz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Fanconi anemia is associated with a defect in the BRCA2 partner PALB2
Bing Xia et al.
NATURE GENETICS (2007)
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Sarah Reid et al.
NATURE GENETICS (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2
Bing Xia et al.
MOLECULAR CELL (2006)
Genomic rearrangements in the BRCA1 and BRCA2 genes
S Mazoyer
HUMAN MUTATION (2005)
Share Paper
